Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Wilkinson

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
European Journal of Cancer & Clinical Oncology|July 1, 1984
A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphomaW P Steward, I D Todd, M Harris, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancerA R Clamp, J Mäenpää, D Cruickshank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphomaR Pettengell, J A Radford, G R Morgenstern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patientsJ A Radford, J S Whelan, A Z Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilR de Wit, J T Roberts, P M Wilkinson, et al.
European Journal of Cancer|November 1, 1980
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)G Blackledge, H Bush, J Chang, et al.
British Journal of Cancer|March 6, 2003
Carcinosarcoma of the ovaryM A Harris, L M Delap, P S Sengupta, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
European Journal of Cancer & Clinical Oncology|July 1, 1984
A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphomaW P Steward, I D Todd, M Harris, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancerA R Clamp, J Mäenpää, D Cruickshank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphomaR Pettengell, J A Radford, G R Morgenstern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1994
Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patientsJ A Radford, J S Whelan, A Z Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's diseaseJ A Radford, D Crowther, A Z Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilR de Wit, J T Roberts, P M Wilkinson, et al.
European Journal of Cancer|November 1, 1980
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)G Blackledge, H Bush, J Chang, et al.
British Journal of Cancer|March 6, 2003
Carcinosarcoma of the ovaryM A Harris, L M Delap, P S Sengupta, et al.
Pageof 8